NCT03338478View on ClinicalTrials.gov

Balance and Anti-Epileptic Drugs

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

May 30, 2018

Study Completion Date

May 30, 2018

Conditions
Epilepsy
Interventions
DIAGNOSTIC_TEST

Wii Balance Board

Participants will stand on the Wii Balance Board with eyes open, eyes closed, one two feet, and then standing on one leg at each study visit.

Trial Locations (1)

03756

Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
collaborator

American Epilepsy Society

OTHER

lead

Erik J. Kobylarz

OTHER

NCT03338478 - Balance and Anti-Epileptic Drugs | Biotech Hunter | Biotech Hunter